chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Janssen COVID-19 Vaccine EUA  I did not feel well within a minute or so of receiving the shot - not an allergic reaction per se. The nurses took my blood pressure and it was 200+/100+ and HR was 108. They continued to monitor and it slowly went down over the course of the 45 minutes I was there. Upon departure, BP reading was at about 160/90. I monitored that evening and Sunday and was normal most of the time. I did have a similar feeling Sunday afternoon and Monday afternoon, and when I checked my BP it was about 150/90 and HR was elevated (between 100-115bpm). Eventually I felt better, excluding expected side effects I've had - fever, aches, and fatigue. As of Tuesday (today as of writing), I am feeling better than yesterday, less fatigue and no fever thus far. I am hoping no more episodes with the elevated BP and HR occur today or in the near future. I did notify my physician about this and he asked me to monitor my BP for the next week, stay hydrated, and report back if no improvement in BP readings.
L arm weakness, pain, L anterior Chest wall tenderness onset later that afternoon. worse with movement, couldn't get dress herself afterwards
Patient states that numbness started at top of left arm, by midnight numbness was from top of left arm  to about 3/4 down arm. Numbness still the same.
Child was given PROQUAD on 10/21/13. That PM her leg started to get red and swell. Swelling cont. to get worse child came to ER 10/22/13 and clinic 10/23/13 due to swelling spreading. Child was give KEFLEX for skin infection.
AROUND 3PM: FATIGUED AND DIFFICULTY CONCENTRATING. AT 12MIDNIGHT: CHILLS, HEADACHE, JOINT PAIN, TEETH WERE CHATTERING, MUSCLES WERE SORE. STOMACH WAS QUEASY. NEXT DAY: FEELING  EXHAUSTED AND "HUNG OVER." WEAK AND ACHY. TOOK IBUPROFEN, REST, AND FLUIDS.
This spontaneous report was received from a physician via field representative regarding a 2 year old male patient. Concurrent condition and medical history were not provided. Approximately in November 2014 (reported as: one year ago), the patient was vaccinated with first dose of (Oka/Merck) VARIVAX, (route, frequency, dose and lot number were not provided). Concomitant therapies were not provided. On an unknown date, the patient experienced shingles. The outcome of herpes zoster was not recovered. The primary reporter did not provide the causality among (Oka/Merck) VARIVAX with shingles. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot # was reported as "L012837" exp. "11-MAR-2018", (dose and route were not provided. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
tight chest; shortness of breath; This is a spontaneous report from a contactable consumer. A 41 year old female patient (not pregnant, also at time of vaccination) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Right on 14Oct2021 at 41 years old (Batch/Lot Number: 30155BA) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced tight chest and shortness of breath 30 mins after shot on 14Oct2021. Lasted 2 hours, no treatment given. The outcome of the events was recovering. Facility type vaccine: Workplace clinic. No covid prior vaccination. Not covid tested post vaccination.  Follow-Up (08Nov2021): Follow-up attempts are completed. No further information is expected.
Patient's parent completed vaccine consent form with DOB 2/18/2009. True DOB is 2/18/2010. Error was caught by web server months later. Telephoned parent to confirm patient's true DOB. Parent reported no adverse effects to note from receiving the Pfizer 12+ vaccine and was unconcerned, remarking that "he was just a few months shy of his 12th birthday." I noted that the purpose of the call today was simply to close the loop for error documentation, document that he did not have an adverse reaction, and mentioned the risk of myocarditis in young males receiving mRNA vaccine.
Information has been received from a physician concerning a female patient (demographics unknown), who on an unspecified date was vaccinated with a dose of PNEUMOVAX23 (dose, route and lot # not provided). It was reported that, on an unknown date, the patient experienced pain and "swelling" at the injection site after receiving PNEUMOVAX23. The outcome for pain and "swelling" at the injection site was unknown. Relatedness for pain and "swelling" at the injection site was not reported for PNEUMOVAX23. Additional information has been requested.
Her right foot is still hard, it goes numb; Her right foot is still hard, it goes numb; Feels like it weights a hundred pounds; foot still hurts; Couldn't move the right Hip and below; Itchiness; Red patches; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb), LIMB DISCOMFORT (Feels like it weights a hundred pounds), PAIN IN EXTREMITY (Arm pain) and PRURITUS (Itchiness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroiditis. Concomitant products included AMLODIPINE, ATORVASTATIN, VITAMINS NOS, OXYBUTYNIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and OMEPRAZOLE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 16-Feb-2021, the patient experienced PRURITUS (Itchiness) and ERYTHEMA (Red patches). On 18-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Couldn't move the right Hip and below). In March 2021, the patient experienced HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb), LIMB DISCOMFORT (Feels like it weights a hundred pounds) and PAIN IN EXTREMITY (foot still hurts). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. At the time of the report, HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb) and LIMB DISCOMFORT (Feels like it weights a hundred pounds) outcome was unknown, PAIN IN EXTREMITY (Arm pain), PRURITUS (Itchiness), ERYTHEMA (Red patches) and MUSCULOSKELETAL DISCOMFORT (Couldn't move the right Hip and below) was resolving and PAIN IN EXTREMITY (foot still hurts) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Computerised tomogram: (normal) Normal. In March 2021, Computerised tomogram: (normal) CT scan was clear..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included an unspecified thyroid medication. Treatment for the events included topical cream and unknown pills.   Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2021: New event right foot is still hard, it goes numb and feels like it weights a hundred pounds were reported. New lab test CT scan was reported. On 09-Jul-2021: Event added.
Patient received a third dose; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 81-year-old male patient who received Herpes zoster (Shingrix) (batch number 2KK72, expiry date 17th June 2024) for prophylaxis.   On 14th February 2023, the patient received the 3rd dose of Shingrix. On 14th February 2023, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 14-FEB-2023 Reporter's comments: The pharmacy manager had reported that, not immunocompromised patient received a third dose of Shingrix. The reporter had consented to follow-up. Additional supportive information: At the time of reporting, the patient who was not immunocompromised had received a third dose of Shingrix vaccine, which had led to extra dose administered.
Approximately 4 hours after the Shingrix vaccination I began experiencing tightness in my chest and  a little trouble breathing. It lasted about 30 minutes. About 6 hours later the same incident occurred. I don?t have asthma and never had experienced difficulty in breathing.
On the day following the injection parent noted local reaction at injection site, redness, swelling thigh -> knee pt. experienced sl. pain. thigh warm to touch.
Localized pain, edema, redness 1 wk following vaccine, chest pain, pleurisy 1-2 wks following vaccine.
A hive started to form on the evening of February 5, 2021, at approximately 5:00 PM. The hive reduced to a small rash. The muscle at the injection site was swollen and tender. By the next morning, February 6, 2021 the muscle had reduced and was not swollen or tender. The rash seems gone. The skin has a red spot approximately 3 inches by 3 inches surrounding the injection site area that is warm to the touch and sometimes itchy or irritated.
Two days post vax, on 06/14, the child was observed as his lips turned blue and finger slightly blue. His temperature was 102 and he had a reddened left lateral thigh. He was taken to the ER where his temperature reached 104. He was seen in the clinic for follow up 7/13, and his thigh was noted as having a pea sized knot.
Rash under both eyes down side of face and forehead - could be allergic Rxn. Fever 12-36 hrs post injection. Arm pain stopped Tues 10/20. Rash started Wed 10/31/2018 - considered normal.
Fully vaccinated with two doses of Pfizer. Tested positive for COVID 19 on 01/21/2022. Admitted to the hospital on 01/21/2022. Expired on 02/06/2022 while still hospitalized.
pAIN; Fever; Upset stomach; This case was reported by a consumer via other manufacturer and described the occurrence of generalized aching in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included adalimumab (Humira) for ulcerative colitis.   On an unknown date, the patient received the 2nd dose of Shingrix and Humira (subcutaneous) at an unknown dose and frequency. On an unknown date, immediately after receiving Shingrix, the patient experienced generalized aching, fever and upset stomach. The action taken with Humira was unknown. On an unknown date, the outcome of the generalized aching, fever and upset stomach were unknown.   It was unknown if the reporter considered the generalized aching, fever and upset stomach to be related to Shingrix.  Additional details were provided as follows: Age at vaccination was not reported. The patient did not have any medical history. Concomitant drugs not reported. It was reported that the patient experienced vaccination adverse reaction fever, body aches, and upset stomach that occurred right after second shingrix vaccine with humira (adalimumab). On an unknown date, the patient's COVID 19 test was Negative. It was unknown if the reporter considered the generalized aching, fever and upset stomach to be related to Humira.
Rather severe back ache (lumbar & thoracic) to the point that I could not bend over, twist to either side or even cough without a severe stabbing pain and then general soreness.
Patient did not have any adverse reactions to vaccine. Patient is behind on vaccines and received Kinirix before recommended age to give.
Mother called to report that pt had a febrile seizure at approximately midnight on 1/4/11. Was taken to ED and discharged with Ibuprofen Q 6HR for 2 days.
to MD in AM of 24APR96 red throat-no fever;APAP given 130PM vax given 2PM,APAP given 5PM&6PM started screaming&jerking;episodes of staring into space,temp 101.8 under arm;cried all noc;seen by MD 11:40 25APR96;put on motrin;ran T
Shortly after getting the vaccine as I was sitting in observation I started feeling a tightness in my chest. I couldn't fully catch my breath and I was dizzy. The nurse and Dr. Of the pharmacy came and brought me water and I described how I felt. They encouraged me to wait a while longer  The pharmacy Dr. Asked could it be anxiety about getting the shot. I said No. I was comfort about getting it that is why I came. I ask was this normal for me to feel this way, with my chest feeling tight, like something was sitting on it, he said no. He checked on me again about 5mins later. Another 5-10 minutes the nurses came to check on me and gave me a paper of what to do if I still felt uncomfortable, which was go to the hospital. After talking to my husband we decided to leave, hoping fresh air would help relieve the pain. While.leaving I felt dizzy and my hands were tingling. We left and monitored my symptoms at home.
Little pain on injection site after first primary shot/Little pain on injection site after 2nd primary shot/Little pain on injection site after first Monovalent Booster/Little pain on injection site after 2nd  Monovalent Booster; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Little pain on injection site after first primary shot/Little pain on injection site after 2nd primary shot/Little pain on injection site after first Monovalent Booster/Little pain on injection site after 2nd  Monovalent Booster) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Little pain on injection site after first primary shot/Little pain on injection site after 2nd primary shot/Little pain on injection site after first Monovalent Booster/Little pain on injection site after 2nd  Monovalent Booster). At the time of the report, VACCINATION SITE PAIN (Little pain on injection site after first primary shot/Little pain on injection site after 2nd primary shot/Little pain on injection site after first Monovalent Booster/Little pain on injection site after 2nd  Monovalent Booster) outcome was unknown.            No concomitant products were reported.  Patient received two primary and two Monovalent boosters and a Bivalent shot. Patient took bivalent booster dose On 04Oct2022 (Lot number AS7162B & Exp. Date 20MAY2023). Patient stated, that the receipt for the Bivalent shot states, Bivalent Booster and has an NDC number on it. Patient stated, that he did not have any side effects after the Bivalent shot. He had a little pain on injection site after the first 4 shots.  No treatment drugs were reported.
Flu like symptoms; Pain; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms and pain. On an unknown date, the outcome of the influenza-like symptoms and pain were recovering/resolving.   It was unknown if the reporter considered the influenza-like symptoms and pain to be related to Shingrix.  Additional details were provided as follows: The patient's wife reported this case. The age at vaccination was not reported. The patient had very bad achy pains and very flu like symptoms. The patient had these problems for over a week and a half and they were just beginning to settle down. The patient was wondering if the patien should take the 2nd shot and what would be the problems with not taking the second shot. This case has been linked to US2019AMR073800, reported by the same reporter for herself.
This spontaneous report was received from a registered nurse concerning an unspecified number of patients of an unknown age and gender. The patient's relevant medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date in July 2015, unspecified number of patients received improperly stored VARIVAX, lot number reported as L015416 with expiration date on 01-AUG-2016 (dose, strength and frequency were not provided). No doses were administered past the expiration date. No symptoms reported. According to the reporter, there were no previous temperature excursions and the temperature and the time frame excursions were reported as: -11.2C for 360 hours, -11.1C for 480 hours and -10.7C for 1296 hours. No Product Quality Complaint (PQC) was involved. Lot numbers L015416 is an invalid lot number for VARIVAX. On 07-NOV-2016, All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a office manager refers to patients of unspecified demographics. Reporter stated that doses of improperly stored VAQTA 25/0.5 (units unspecified) (lot number, expiry date unspecified) were administered to unspecified patients on unspecified dates. No adverse events were reported. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Extreme swelling in my right leg from about 6 inches below my knee to about 6 inches above my knee. There was lesser swelling above that area. This is consistent with the area that had post-op infection in it in 1978. It was only in the area of the right knee. It started suddenly after no injury. There was no problem when I went to bed on 2/28/21, but when I woke up during the night, it was so swollen that the skin felt tight. It remained that swollen and was that way when I went to be on 3/8/21. When I woke up on 3/9/21, the swelling had suddenly disappeared, not a partial reducing like one would expect with an injury. On 3/5/21, I had a routine appointment with the physical therapist. I could not bend my knee to the extent that I normally could and he noticed that, but neither of us made any possible connection to the vaccine. When the swelling disappeared suddenly is when I started thinking and suspected that it could possibly be from the vaccine.
Rash presenting 40-48 hours after 2nd dose.  Scalp, face, torso.  Slightly itchy, patches of redness chest, back, stomach, crotch, face, scalp.  Took Benadryl and it helped slightly with redness but has persisted through next day, although redness isn't as vivid.
Body aches & severe joint pain, from shoulders down to toes, headache & neck pain, sore throat.
Sever  headache,  fever, dry cough, sore throat, fatigue, muscle pain
Pt experienced vomiting and diarrhea first night post vax only. Pt complained of headaches, sleeping allot each day (usually very active, hardly ever ill), developed tremors especially hands could hardly write. Would think he was better, then would regress again. Pt had general malaise most of the time.
About 30 seconds to one minute after vaccine, throat became very dry. After about 1 minute 30 seconds after vaccine I began to get raised and itchy welts on the left side of my neck. Then I began to get raised welts going down my chest.
I have the regular flu-like symptoms, as well as severe burning nerve pain throughout my body.  This didn't present until I received the second dose of the vaccine.  I haven't sought help, but will if it doesn't go away in a day.
Fever 101+, began 5/15, still ongoing Site rash, began 5/16, still ongoing
MODERATE ALLERGIC REACTION WITH RASH AND ITCHING WITHIN ABOUT 10 MINUTES FOLLOWING FLU SHOT, NO RESPIRATORY PROBLEMS. GIVEN 50mg BENEDRYL IM. SENT VIA AMBULANCE TO ER. PT HAS H/O PREVIOUS FLU VACCINATION WITHOUT REACTION. ONLY KNOWN ALLERGY WAS TO SULFA. FOLLOW-UP PHONE CALL LATER IN DAY FOUND PT RECOVERING AT HOME AND PLANNING TO RETURN TO WORK THE NEXT DAY.
pinpoint needle pain; excessive itching (back, torso, chest)/inside of his elbows and knee itch; excessive scratching (back, torso, chest); two red spots, on elbow and on knee; felt like there was an elephant on his chest (chest pain); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (pinpoint needle pain), PRURITUS (excessive itching (back, torso, chest)/inside of his elbows and knee itch), PRURITUS (excessive scratching (back, torso, chest)), RASH MACULAR (two red spots, on elbow and on knee) and CHEST PAIN (felt like there was an elephant on his chest (chest pain)) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Kidney stone, Blood pressure abnormal, Acid reflux (oesophageal), Cancer, Type 2 diabetes mellitus and Cholesterol high. Concomitant products included FAMOTIDINE for Acid reflux (oesophageal), FLUTICASONE and LORATADINE for Allergy, BACLOFEN for Back pain, TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Bladder disorder NOS, AMLODIPINE for Blood pressure management, FINASTERIDE for Cancer, ROSUVASTATIN for Cholesterol high, LATANOPROST (LATANOPROST 1A PHARMA) for Glaucoma, ASPIRIN [ACETYLSALICYLIC ACID], ISOSORBIDE, LOSARTAN and METOPROLOL for Heart disease, unspecified, ALLOPURINOL SODIUM (ALLOPURINOL [ALLOPURINOL SODIUM]) for Kidney stone prevention, ASCORBIC ACID, CUPRIC OXIDE, DL-ALPHA TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC OXIDE (VISION SHIELD EYE HEALTH) for Macular degeneration, TOPIRAMATE for Tremor, METFORMIN for Type 2 diabetes mellitus, VITAMIN D3 for Vitamin D deficiency, THIOCTIC ACID (ALPHA LIPOIC ACID 400), POLYCARBOPHIL CALCIUM (FIBER), MULTIVITAMIN [VITAMINS NOS], CLOPIDOGREL BISULFATE (PLAVIX) and VITAMIN B12 NOS for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (pinpoint needle pain), PRURITUS (excessive itching (back, torso, chest)/inside of his elbows and knee itch), PRURITUS (excessive scratching (back, torso, chest)), RASH MACULAR (two red spots, on elbow and on knee) and CHEST PAIN (felt like there was an elephant on his chest (chest pain)). The patient was treated with NITROGLYCERIN (sublingual) for Chest pain, at a dose of 0.4 milligram. At the time of the report, PAIN (pinpoint needle pain), PRURITUS (excessive itching (back, torso, chest)/inside of his elbows and knee itch), PRURITUS (excessive scratching (back, torso, chest)), RASH MACULAR (two red spots, on elbow and on knee) and CHEST PAIN (felt like there was an elephant on his chest (chest pain)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.